Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients with Type 2 Diabetes

Study identifier:H8O-IT-B014

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

EBIRIOS - Exenatide and Basal Insulins Use in the Real Setting: an Italian Observational Study in Patients with Type 2 Diabetes and Secondary Failure of Oral Antihyperglycemic Treatment

Medical condition

Type 2 Diabetes Mellitus

Phase

-

Healthy volunteers

No

Study drug

exenatide, basal insulin

Sex

All

Actual Enrollment

888

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Apr 2010
Primary Completion Date: 01 May 2012
Study Completion Date: 01 May 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Mar 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

Eli Lilly and Company

Inclusion and exclusion criteria